The challenges of bringing autologous HSP-based vaccines to commercial reality.

Gordon, Neal F; Clark, Brian L

Gordon, Neal F; Clark, Brian L.

Affiliation

Gordon NF; Antigenics Inc., Lexington, MA 02421, USA. ngordon@antigenics.com

Methods ; 32(1): 63-9, 2004 Jan.

Article in En | MEDLINE | ID: mdl-14624879

Subject(s)

Heat-Shock Proteins/immunology; Vaccines, Synthetic/immunology; Antibodies, Monoclonal/immunology; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Breast Neoplasms/immunology; Breast Neoplasms/therapy; Drug Industry; Female; Humans; Immunotherapy/methods; Trastuzumab; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Heat-Shock Proteins Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Methods Journal subject: BIOQUIMICA Year: 2004 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links